Pain in chemotherapy-induced neuropathy - More than neuropathic?

被引:47
|
作者
Geber, Christian [1 ]
Breimhorst, Markus [1 ]
Burbach, Berenike [1 ]
Egenolf, Christina [1 ]
Baier, Bernhard [1 ]
Fechir, Marcel [1 ]
Koerber, Juergen [2 ]
Treede, Rolf-Detlef [3 ]
Vogt, Thomas [1 ]
Birklein, Frank [1 ,4 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med, Neurol Klin & Poliklin, D-55122 Mainz, Germany
[2] Rehaklin Nahetal, Bad Kreuznach, Germany
[3] Heidelberg Univ, Med Fak Mannheim, Zentrum Biomed & Med Tech CBTM, Mannheim, Germany
[4] Murdoch Univ, Perth, WA, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Chemotherapy; Polyneuropathy; Quantitative sensory testing; Musculoskeletal pain; Neuropathic pain; Pain drawings; Mixed pain; MYOFASCIAL TRIGGER POINTS; MUSCULOSKELETAL PAIN; EFNS GUIDELINES; GRADING SYSTEM; PRIMARY-CARE; OXALIPLATIN; PREVALENCE; PERCEPTION; MECHANISMS; SECONDARY;
D O I
10.1016/j.pain.2013.08.028
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Chemotherapy-induced neuropathy (CIN) is an adverse effect of chemotherapy. Pain in CIN might comprise neuropathic and nonneuropathic (ie, musculoskeletal) pain components, which might be characterized by pain patterns, electrophysiology, and somatosensory profiling. Included were 146 patients (100 female, 46 male; aged 56 +/- 0.8 years) with CIN arising from different chemotherapy regimens. Patients were characterized clinically through nerve conduction studies (NCS) and quantitative sensory testing (QST). Questionnaires for pain (McGill) and anxiety/depression (Hospital Anxiety and Depression Scale) were supplied. Patients were followed-up after 17 days. Large-(61%) and mixed- (35%) fibre neuropathies were more frequent than small-fibre neuropathy (1.4%). The 5 major chemotherapeutic regimens impacted differently on large-but not on small-fibre function and did not predict painfulness. Chronic pain associated with CIN was reported in 41.7%. Painless and painful CIN did not differ in QST profiles or electrophysiological findings, but different somatosensory patterns were found in CIN subgroups (pain at rest [RestP], n = 25; movement-associated pain [MovP], n = 15; both pain characteristics [MovP+RestP], n = 21; or no pain [NonP], n = 85): small-fibre function (cold-detection threshold, CDT: z score: -1.46 +/- 0.21, P < 0.01) was most impaired in RestP; mechanical hyperalgesia was exclusively found in MovP (z score: +0.81 +/- 0.30, P < 0.05). "Anxiety" discriminated between painful and painless CIN; "CDT" and "anxiety" discriminated between patients with ongoing (RestP) and movement-associated pain (MovP) or pain components (MovP+RestP). The detrimental effect of chemotherapy on large fibres failed to differentiate painful from painless CIN. Patients stratified for musculoskeletal or neuropathic pain, however, differed in psychological and somatosensory parameters. This stratification might allow for the application of a more specific therapy. (C) 2013 International Association for the Study of Pain. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:2877 / 2887
页数:11
相关论文
共 50 条
  • [1] Pain in chemotherapy-induced neuropathy - More than neuropathic? Reply
    Tesarz, Jonas
    Gerhardt, Andreas
    Treede, Rolf-Detlef
    Eich, Wolfgang
    PAIN, 2013, 154 (12) : 2888 - 2890
  • [2] Chemotherapy-induced peripheral neuropathy and neuropathic pain
    Schuler, U.
    Heller, S.
    SCHMERZ, 2017, 31 (04): : 413 - 425
  • [3] Chemotherapy-induced peripheral neuropathic pain
    Gupta, R.
    Bhaskar, A.
    BJA EDUCATION, 2016, 16 (04) : 115 - 119
  • [4] Neuroimmune communication in chemotherapy-induced neuropathic pain
    Malcangio, M.
    Montague, K.
    GLIA, 2017, 65 : E96 - E97
  • [5] Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain
    Brandolini, Laura
    d'Angelo, Michele
    Antonosante, Andrea
    Cimini, Annamaria
    Allegretti, Marcello
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12)
  • [6] Pain from chemotherapy-induced peripheral neuropathy
    van Dasselaar T.
    Dahan A.
    Niesters M.
    Huisarts en wetenschap, 2023, 66 (7-8) : 36 - 39
  • [7] Neuropathic Pain Affects Quality of Life in Breast Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy
    Jheng, You-Wun
    Chan, Ya-Ning
    Wu, Chih-Jung
    Lin, Ming-Wei
    Tseng, Ling-Ming
    Wang, Ya-Jung
    PAIN MANAGEMENT NURSING, 2024, 25 (03) : 308 - 315
  • [8] Is Chemotherapy-induced Peripheral Neuropathy More Than Just a Peripheral Nervous System Disorder?
    Dougherty, Patrick M.
    ANESTHESIOLOGY, 2016, 124 (05) : 992 - 993
  • [9] Chemotherapy-Induced Peripheral Neuropathic Pain and Rodent Models
    Hama, Aldric
    Takamatsu, Hiroyuki
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (01) : 7 - 19
  • [10] Can Medical Herbs Stimulate Regeneration or Neuroprotection and Treat Neuropathic Pain in Chemotherapy-Induced Peripheral Neuropathy?
    Schroeder, Sven
    Beckmann, Kathrin
    Franconi, Giovanna
    Meyer-Hamme, Gesa
    Friedemann, Thomas
    Greten, Henry Johannes
    Rostock, Matthias
    Efferth, Thomas
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013